BRAF V600E is the most common early driver in differentiated thyroid cancer, and 50% of ATC cases have a history or are associated with DTC, hence 10% to 50% of ATC cases harbor this mutation (18). Here, BRAF is linked to differentiated thyroid carcinoma.